IRIS
CONDORELLI, GEROLAMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.819
EU - Europa 1.870
AS - Asia 1.436
AF - Africa 50
SA - Sud America 33
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.711
SG - Singapore 627
IT - Italia 609
CN - Cina 434
DE - Germania 294
HK - Hong Kong 256
FI - Finlandia 227
RU - Federazione Russa 152
NL - Olanda 138
IE - Irlanda 120
SE - Svezia 103
CA - Canada 102
UA - Ucraina 89
GB - Regno Unito 48
FR - Francia 45
VN - Vietnam 40
CI - Costa d'Avorio 38
IN - India 37
BR - Brasile 28
TR - Turchia 15
BE - Belgio 11
LT - Lituania 7
ET - Etiopia 6
IR - Iran 6
PK - Pakistan 6
CZ - Repubblica Ceca 5
MX - Messico 5
AU - Australia 4
BG - Bulgaria 4
CH - Svizzera 4
ES - Italia 4
AT - Austria 3
BD - Bangladesh 3
JP - Giappone 3
RS - Serbia 3
ZA - Sudafrica 3
CO - Colombia 2
EU - Europa 2
KE - Kenya 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BZ - Belize 1
EC - Ecuador 1
EG - Egitto 1
GY - Guiana 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
LU - Lussemburgo 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.216
Salva come PNG Salva come JPEG
Città #
Chandler 453
Singapore 451
Hong Kong 255
Santa Clara 236
Ashburn 205
Millbury 149
Amsterdam 134
Jacksonville 134
Munich 133
Princeton 129
Napoli 126
Helsinki 108
Nanjing 97
Boston 95
Ottawa 88
Naples 84
Wilmington 81
Beijing 77
Rome 64
Des Moines 47
Nanchang 40
Dong Ket 36
Shenyang 34
Seattle 29
Pune 26
Lawrence 25
Cagliari 24
Houston 24
Redwood City 23
Falls Church 22
Hebei 22
Jiaxing 22
San Giorgio del Sannio 22
Tianjin 19
Woodbridge 17
Dublin 16
Milan 16
Washington 16
Verona 15
Changsha 14
Caserta 13
Norwalk 13
Boardman 12
Nuremberg 12
Toronto 12
Castelvetere sul Calore 11
Moscow 11
Shanghai 11
Falkenstein 10
Brussels 9
Dallas 9
Ann Arbor 7
Fairfield 7
Fisciano 7
Frankfurt am Main 7
Göteborg 7
San Felice A Cancello 7
Addis Ababa 6
Afragola 6
Guangzhou 6
Kronberg 6
Kunming 6
Ningbo 6
Saint Petersburg 6
Zhengzhou 6
Avellino 5
Brno 5
Changchun 5
Gurgaon 5
Los Angeles 5
Redmond 5
Vercelli 5
Aversa 4
Castries 4
Formia 4
Ho Chi Minh City 4
Istanbul 4
Jinan 4
Orange 4
Prayagraj 4
Évry 4
Belgrade 3
Camden 3
Ercolano 3
Hangzhou 3
Indiana 3
Isfahan 3
Islamabad 3
Johannesburg 3
London 3
Nigde 3
Noble Park 3
Sofia 3
Stockholm 3
Swindon 3
Vienna 3
Altamura 2
Ardabil 2
Augusta 2
Basel 2
Totale 3.945
Salva come PNG Salva come JPEG
Nome #
Recent Advance in Biosensors for microRNAs Detection in Cancer 140
Nucleic acids in human glioma treatment: innovative approaches and recent results. 134
Anti-breast cancer exosome aptamer for diagnostic and therapeutic uses 102
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway 87
MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer 87
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS 84
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 77
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 70
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 67
Late INa Inhibition with Ranolazine Blunts Doxorubicin- Induced Cardiac Dysfunction and Remodeling in Mice 66
Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. 65
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 65
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 63
MiR-216a acts as a negative regulator of breast cancer by modulating stemness properties and tumor microenvironment 62
ANTHRACYCLINE INDUCED CARDIOTOXICITY IN MICE IS PREVENTED BY LATE INA INHIBITION WITH RANOLAZINE, WITH IMPROVEMENT IN HEART FUNCTION, FIBROSIS, APOPTOSIS 61
SIROLIMUS-ELUTING STENT IMPLANTATION IN DIABETIC PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE 59
PED regulates cell migration/invasion processes in human non small cell lung cancer cells through Rac1. 59
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. 57
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. 57
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells 57
Autocrine production of IL-4 and IL-10 is required for survival and growth of thyroid cancer cells 56
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b 56
Contrast-induced acute kidney injury: Potential new strategies 54
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects 54
The anticancer mTOR-inhibitor temsirolimus induces cardiac dysfunction in mice 53
Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus 53
Potential and challenges of aptamers as specific carriers of therapeutic oligonucleotides for precision medicine in cancer 53
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 53
A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. 52
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRbeta Aptamer. 52
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 52
Targeting Insulin Receptor with a Novel Internalizing Aptamer 50
Epigenetic Regulation of miR-212 Expression in Lung Cancer 49
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury 49
Akt regulates drugs induced cell death through the anti-apoptotic protein Bcl-w 48
Akt and Erk 8 activity regulation in cellular proliferation control 48
In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. 48
Renal insufficiency after contrast media administration trial II (REMEDIAL II): Renalguard system in high-risk patients for contrast-induced acute kidney injury 48
Endothelial Progenitor Cells and Percutaneous Coronary Artery Intervention: Editorial to: “Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells after Percutaneous Coronary Intervention (HIPOCRATES Study)” by A. Eisen et al 48
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial. 48
Multifunctional role of PED/PEA15 in cell death and cell motility in human non small cell lung cancer (NSCLC). 47
An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells. 47
Modulating the crosstalk between the tumor and the microenvironment using sirna: A flexible strategy for breast cancer treatment 47
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 47
Cell Death-based therapy 46
Differential role of insulin receptor substrate (IRS)-1 and IRS-2 in L6 skeletal muscle cells expressing the Arg1152 --> Gln insulin receptor. 46
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications 46
In skeletal muscle, glucose storage and oxidation are differentially impaired by the IR1152 mutant receptor. 45
Insulin-activated PKCb bypasses Ras and stimulates MAPKinase activity and cell proliferation in muscle cells 45
PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. 45
"ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. 45
Therapeutic strategies to prevent contrast-induced acute kidney injury 45
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer 45
Impact of microvascular complications on outcome after coronary stent implantations in diabetic patients 43
Antiphosphotyrosine immunoprecipitation of an insulin-stimulated receptor phosphatase activity from FRTL5 cells. 43
Contrast agents and renal cell apoptosis 43
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. 43
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 43
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 43
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. 42
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. 42
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay. 42
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 42
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells 42
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus 41
Endothelial progenitor cells in coronary artery disease 41
Aptamer chimeras for therapeutic delivery: The challenging perspectives 41
IMPACT OF GLYCAEMIC AND LIPID CONTROL ON OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN DIABETIC PATIENTS. 40
Caratterizzazione dei meccanismi molecolari del danno indotto da mezzo di contrasto in cellule renali umane. 40
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity. 40
Antifouling strategies of nanoparticles for diagnostic and therapeutic application: A systematic review of the literature 40
Molecular basis of impaired insulin-stimulated cardiac glucose utilization in spontaneously hypertensive rats. 39
Optimisation of TAP-TAG purification in PED/PEA-15 interactoma studies 39
La tirosino fosfatasi SHP-1 come nuovo marker prognostico del carcinoma mammario umano 39
miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. 39
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells 39
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. 38
Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells 38
Novel Biomarkers for Contrast-Induced Acute Kidney Injury 38
RenalGuard system in high-risk patients for contrast-induced acute kidney injury. 38
Apamers against Glioblastoma 38
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 37
TNF-alfa signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alfa receptor 37
Antiphosphotyrosine immunoprecipitation of an insulin-stimulated receptor phosphatase activity from FRTL5 cells 37
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. 37
The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy 37
Functional importance of Insulin-like Growth Factor I receptor COOH-terminal region tyrosine phosphorylation sites. 36
Hydration in contrast-induced acute kidney injury 36
PED mediates AKT dependent chemoresistance in human breast cancer cells 35
Multiple members of the Mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function 35
miR221/222 in cancer: their role in tumor progression and response to therapy. 35
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals 34
Caratterizzazione della proteina antiapoptotica bclw come nuovo interattore della serin treonin chinasi AKT. 34
RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY 34
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. 34
Nucleic acids delivering nucleic acids. 34
Combined targeting of glioblastoma stem-like cells by neutralizing RNA-bio-drugs for STAT3 34
Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study 33
MicroRNAs signatures of TRAIL resistant phenotype in human non small cell lung cancer. 33
Apoptosis and Contrast Nephrotoxicity. 33
Totale 4.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 0 0 0 0 0 0 12 5 49 65 74
2020/2021539 39 22 79 23 38 74 56 51 43 15 48 51
2021/2022879 53 1 1 7 46 35 10 32 129 57 133 375
2022/20231.121 165 78 34 72 137 132 5 104 195 134 47 18
2023/2024886 46 135 75 67 43 165 20 108 13 14 144 56
2024/20251.839 214 288 18 54 134 378 507 246 0 0 0 0
Totale 6.487